StimCardio
StimCardio Medical (formerly CardiaCare) is a Los Angeles-based clinical-stage medical device company with science operations in Ness Ziona, Israel.
Position in SVTRnew
Snapshot 2026-11-05- Startup SignalsRankedof 2,330
- Life SciencesRankedof 245
- Medtech DeviceRankedof 48
About
StimCardio Medical (formerly CardiaCare) is a Los Angeles-based clinical-stage medical device company with science operations in Ness Ziona, Israel. Its wrist-worn closed-loop system Rhyvive combines non-invasive median nerve stimulation with continuous physiological sensing and machine learning-enabled analysis to reduce atrial fibrillation recurrence after catheter ablation.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Funding history
- 2026-10-29Series A$30M
Investors · Metis MedTech, Catalyst Health VenturesSource · stimcardio.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- StimCardio
Wrist-worn closed-loop neuromodulation device to reduce recurrence after atrial fibrillation ablation
Series A · 2026-10
—
United States
BusinessLatest roundTotal raisedDateChina
BusinessLatest roundTotal raisedDate- BCI-Sonics
Non-invasive AI ultrasound brain-computer interface (transcranial focused ultrasound neuromodulation + multimodal brain reading and AI neural decoding…
Series A · $42M · 2026-09
$42M - Genlight Neurotech
Data-driven full-stack brain-computer interface platform spanning three technology platforms: BCI neuromodulation…
Series D+ · 2026-09
— - 思博慧医
Fully autonomous magnetically guided neurointerventional surgical robot driven by a VLA large model
Series A · 2026-09
—
Europe
BusinessLatest roundTotal raisedDate- Soundsafe Care
Robotic focused ultrasound devices for noninvasive tumor ablation, launching first with veterinary certification…
$2M
$2M - MintNeuro
Imperial College London spinout developing composable chip modules for neural signal acquisition, electrical stimulation…
Undisclosed · 2026-10
— - Hypervision Surgical
Surgical intelligence venture incubated at King's College London; AI-driven hyperspectral imaging assesses tissue status in real time during surgery
Series A · $23M · 2026-05
$23M
Other / unspecified
BusinessLatest roundTotal raisedDate- IMeditech
R&D and manufacturing of electrospun nanofiber wound care devices, vascular stents, catheters and neurointerventional devices…
$1.1B
$1.1B - LEESOL
Brainwave-synchronizing wearables for sleep and mental health (Sleepisol series, blissol, DAYZER) with AI biosignal analysis
Series A · $1.1B · 2026-02
$1.1B - Sound Blade Medical
Handheld device that uses focused ultrasound to break down diseased tissue non-invasively
Series A · $17M · 2025-02
$17M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Investors that may fit
Y Combinator
39 Life Sciences deals in the last 24 months · 34 at a nearby stage · 32 in Greater LA
Request intro →General Catalyst
38 Life Sciences deals in the last 24 months · 24 at a nearby stage · 34 in Greater LA
Request intro →Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 11 at a nearby stage · 20 in Greater LA
Request intro →Khosla Ventures
21 Life Sciences deals in the last 24 months · 10 at a nearby stage · 20 in Greater LA
Request intro →Thrive Capital
18 Life Sciences deals in the last 24 months · 6 at a nearby stage · 15 in Greater LA
Request intro →Lightspeed
16 Life Sciences deals in the last 24 months · 10 at a nearby stage · 14 in Greater LA
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.